WordNet

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 閉経後女性における子宮出血 postmenopausal uterine bleeding
2. 閉経期のホルモン療法：利益とリスク menopausal hormone therapy benefits and risks
3. 閉経期のホルモン療法で用いる製剤 preparations for menopausal hormone therapy
4. 骨粗鬆症の予防および治療における閉経後のホルモン療法 postmenopausal hormone therapy in the prevention and treatment of osteoporosis
5. 悪性または前癌疾患に関する子宮内膜の評価 evaluation of the endometrium for malignant or premalignant disease

Soy isoflavones (Glycine max) ameliorate hypertriglyceridemia and hepatic steatosis in high fat-fed ovariectomized Wistar rats (an experimental model of postmenopausal obesity).

Panneerselvam S1, Packirisamy RM1, Bobby Z2, Elizabeth Jacob S3, Sridhar MG1.
The Journal of nutritional biochemistry.J Nutr Biochem.2016 Dec;38:57-69. doi: 10.1016/j.jnutbio.2016.08.007. Epub 2016 Sep 8.
Obesity emerged as the major risk factor for metabolic syndrome. Postmenopausal women are more prone to develop obesity than premenopausal women. The absence of safe and effective conventional treatments for postmenopausal obesity has changed the focus to natural products as alternative remedy. We i
PMID 27723468

Impact of Menopause on Pharmacokinetics of Rosuvastatin Compared with Premenopausal Women.

Nazir S1, Iqbal Z2, Nasir F3.
European journal of drug metabolism and pharmacokinetics.Eur J Drug Metab Pharmacokinet.2016 Oct;41(5):505-9. doi: 10.1007/s13318-015-0285-2.
BACKGROUND AND OBJECTIVE: Rosuvastatin is used to treat dyslipidemia and its use is quite frequent among postmenopausal women. Menopause significantly affects the pharmacokinetics of drugs, and altered drug response and therapeutic efficacy may be anticipated in postmenopausal women compared with pr
PMID 26099962

Wang N1, Qin MZ, Cui J.
Zhonghua xin xue guan bing za zhi.Zhonghua Xin Xue Guan Bing Za Zhi.2016 Sep 24;44(9):799-804. doi: 10.3760/cma.j.issn.0253-3758.2016.09.013.
Objective: To compare serum lipid values in premenopausal and postmenopausal women and to evaluate the relationship between menopause and lipid profiles. Methods: From January 2012 to December 2014, a total of 4 131 women aged between 40 and 59 years old were recruited as subjects in the Checkup Dep
PMID 27667280

Reference Interval for the Apolipoprotein B-48 Concentration in Healthy Japanese Individuals

Effects of Pravastatin and Atorvastatin on HDL Cholesterol and Glucose Metabolism in Patients with Dyslipidemia and Glucose Intolerance: The PRAT Study